Anika Therapeutics (ANIK) Change in Acquisitions & Divestments (2015 - 2021)

Anika Therapeutics (ANIK) has 7 years of Change in Acquisitions & Divestments data on file, last reported at $2.5 million in Q1 2021.

• Change in Acquisitions & Divestments for Q1 2021 came in at $2.5 million, down 83.32% year-over-year; the trailing twelve-month figure through Dec 2021 was $2.5 million (down 94.44% YoY), and the FY2021 annual result was $2.5 million, down 94.44% from the prior year.
• Change in Acquisitions & Divestments slipped to $2.5 million in Q1 2021 per ANIK's latest filing, from $18.0 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $58.8 million in Q4 2019 and troughed at $2.5 million in Q1 2021.
• A 5-year average of $16.6 million and a median of $11.5 million in 2018 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2019 and 2021: Change in Acquisitions & Divestments jumped 411.06% in 2019, then plunged 83.32% in 2021.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $10.2 million in 2017, then advanced by 12.2% to $11.5 million in 2018, then jumped by 411.06% to $58.8 million in 2019, then plunged by 69.37% to $18.0 million in 2020, then sank by 86.11% to $2.5 million in 2021.
• Business Quant data shows ANIK's Change in Acquisitions & Divestments at $2.5 million in Q1 2021, $18.0 million in Q4 2020, and $7.0 million in Q3 2020.